| Updating you about cancer causes, prevention, screening, treatment, coping, and more | |  | | Treatment options for people with acute myeloid leukemia (AML) have expanded. The Food and Drug Administration (FDA) has approved quizartinib (Vanflyta) combined with chemotherapy as a first-line treatment for AML with a specific change in the FLT3 gene. | | |  Learn about an NCI-supported study that was launched to improve the care of people with brain tumors called low-grade glioma. To help achieve this goal, the study is exploring new ways to involve people with these tumors in cancer research. | | | | FDA has approved the combination drug niraparib tosylate monohydrate and abiraterone acetate (Akeega) to treat certain adults with metastatic prostate cancer that no longer responds to treatments that lower testosterone levels (castrate resistant). It is used in people who have certain changes in the BRCA1 or BRCA2 gene. | | | Craniopharyngiomas are rare, noncancerous brain tumors that usually form near the pituitary gland and hypothalamus. They may press on nearby areas of the brain and cause problems with growth, vision, and making certain hormones. Learn more about these tumors, including their signs and symptoms and how they are diagnosed and treated. | |  Information specialists at NCI's Cancer Information Service (CIS), NCI's contact center, can help answer your cancer-related questions in English and Spanish. This page tells you how to reach us by phone, chat, or email. | | | | |
No comments:
Post a Comment